aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Neodocs: Instant smartphone lab tests for health optimization.
Neodocs aims to revolutionize personal health management by offering instant lab tests via smartphones. Targeting health optimizers and athletes, Neodocs enables users to collect samples, take pictures, and receive immediate results, focusing on improving key nutritional markers for enhanced performance. Founded by Anurag, Pratik, and Nikunj, the team combines expertise in medical entrepreneurship, AI/ML, and consulting.
Neodocs has made significant strides in democratizing access to health diagnostics, empowering users to take control of their health with ease and accuracy. The founders' diverse backgrounds in medical devices, AI/ML, and strategic consulting have been instrumental in the company's innovation and growth.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Health Data, Lab Tests
Technology
AI, Machine Learning
Tags
Biotech, Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
Global
When was Neodocs founded?
Neodocs was founded in 2020.
Where is Neodocs’s headquarters located?
Neodocs’s headquarters is located in Mumbai, MH, IN.
When was Neodocs’s last funding round?
Neodocs’s most recent funding round was for $166M (USD) in February 2024.
How many employees does Neodocs have?
Neodocs has 17 employees as of Feb 24, 2024.
How much has Neodocs raised to-date?
As of July 05, 2023, Neodocs has raised a total of $166.3M (USD) since Feb 8, 2024.
Add Comparison
Total Raised to Date
$166.3M
USD
Last Update Feb 8, 2024
Last Deal Details
$166M
USD
Feb 8, 2024
Seed
Total Employees Over Time
17
As of Feb 2024
Neodocs Address
Mumbai,
Maharashtra
400063
India
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts